학술논문
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial
Document Type
Article
Author
Source
In The Lancet Gastroenterology & Hepatology December 2023 8(12):1094-1105
Subject
Language
ISSN
2468-1253